Top stories
Critical shortages in clinical trial participants threaten the advancement of dementia therapies, experts warn. Calls are intensifying for better public awareness and engagement strategies to meet the demand for 350,000 trial candidates.
japantimes.co.jp
Geopolitical risks, inflation, and monetary policy are shaping bond and stock markets, with interest rate paths closely monitored by investors. Rising bond yields and rate hikes raise recession risks, as markets brace for further moves from major central banks like the Fed and Bank of Japan.
nzherald.co.nz + 1















